Prime stock recommendation: A consumer durables play gearing for a comeback
Login required to read this article.
Prime stock recommendation: A consumer durables play gearing for a comeback Read More »
Business update
Stock update: Results analysis on our niche capital goods pick
Login required to read this article.
Stock update: Results analysis on our niche capital goods pick Read More »
Godrej Agrovet – what’s firing and what isn’t
Godrej Agrovet is a conglomerate with businesses spread across the agriculture and protein supply chain. It is in animal feeds, palm oil extraction, agrochemicals, dairy and frozen foods. The business has commoditised parts, seasonal parts and valued added parts.
Godrej Agrovet – what’s firing and what isn’t Read More »
IPO Review: Glenmark Life Sciences – Should you invest?
Glenmark Life Sciences (GLS) is a generic API (Active Pharmaceutical Ingredients) manufacturer and a subsidiary of Glenmark Pharmaceuticals. The Glenmark Life Sciences IPO is worth Rs. 1,514 crore, comprising fresh issue of Rs.1,060 crore and an offer for sale worth Rs.454 crore by Glenmark Pharmaceuticals. Should you invest in the IPO of this high-value, non-commoditized API player?
IPO Review: Glenmark Life Sciences – Should you invest? Read More »
Stock review: A healthy player in the diagnostics space
Growth estimates are being placed at a CAGR of around 10% for the next five years for the diagnostics sector, presenting a very attractive opportunity to players that are ready and able to take advantage. Dr Lal Path Labs is a leading diagnostics player, building up its presence outside its traditional stronghold of Delhi.
Stock review: A healthy player in the diagnostics space Read More »
